Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 77-93 , February 2008

Adrenal gland development and defects

  • Petra Kempná, PhD (Postdoctoral Fellow)
    • ,
  • Christa E. Flück, MD (Principal Investigator)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +41 31 632 0499; Fax: +41 31 632 8424.

References 

  1. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocrine Reviews. 1997;18:378–403
  2. Coulter CL. Functional biology of the primate fetal adrenal gland: advances in technology provide new insight. Clinical and Experimental Pharmacology & Physiology. 2004;31:475–484
  3. Miller WL. Molecular biology of steroid hormone synthesis. Endocrine Reviews. 1988;9:295–318
  4. Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. The Journal of Clinical Endocrinology Metabolism. 1984;59:551–555
  5. Havelock JC, Auchus RJ, Rainey WE. The rise in adrenal androgen biosynthesis: adrenarche. Seminars in Reproductive Medicine. 2004;22:337–347
  6. Auchus RJ, Rainey WE. Adrenarche – physiology, biochemistry and human disease. Clinical Endocrinology. 2004;60:288–296
  7. Voutilainen R, Miller WL. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc in human steroidogenic tissues. Proceedings of the National Academy of Sciences of the United States of America. 1987;84:1590–1594
  8. Di Blasio AM, Voutilainen R, Jaffe RB, et al. Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17α-hydroxylase/17,20-lyase) in cultured human fetal adrenal cells. The Journal of Clinical Endocrinology Metabolism. 1987;65:170–175
  9. Hanley NA, Arlt W. The human fetal adrenal cortex and the window of sexual differentiation. Trends in Endocrinology and Metabolism. 2006;17:391–397
  10. Goto M, Piper Hanley K, Marcos J, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. The Journal of Clinical Investigation. 2006;116:953–960
  11. Voutilainen R, Ilvesmaki V, Miettinen PJ. Low expression of 3β-hydroxy-5-ene steroid dehydrogenase gene in human fetal adrenals in vivo; adrenocorticotropin and protein kinase C-dependent regulation in adrenocortical cultures. The Journal of Clinical Endocrinology Metabolism. 1991;72:761–767
  12. Mapes S, Tarantal AF, Parker CR, et al. Adrenocortical cytochrome b5 expression during fetal development of the Rhesus macaque. Endocrinology. 2002;143:1451–1458
  13. Miller WL. Steroid hormone biosynthesis and actions in the materno-feto-placental unit. Clinics in Perinatology. 1998;25:799–817
  14. Sucheston ME, Cannon MS. Development of zonular patterns in the human adrenal gland. Journal of Morphology. 1968;126:477–491
  15. Wrobel KH, Suss F. On the origin and prenatal development of the bovine adrenal gland. Anatomy and Embryology. 1999;199:301–318
  16. Parker KL, Rice DA, Lala DS, et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Progress in Hormone Research. 2002;57:19–36
  17. Else T, Hammer GD. Genetic analysis of adrenal absence: agenesis and aplasia. Trends in Endocrinology and Metabolism. 2005;16:458–468
  18. Coulter CL. Fetal adrenal development: insight gained from adrenal tumors. Trends in Endocrinology and Metabolism. 2005;16:235–242
  19. Discenza MT, Pelletier J. Insights into the physiological role of WT1 from studies of genetically modified mice. Physiological Genomics. 2004;16:287–300
  20. Biason-Lauber A, Konrad D, Navratil F, et al. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. The New England Journal of Medicine. 2004;351:792–798
  21. Kohlhase J, Wischermann A, Reichenbach H, et al. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nature Genetics. 1998;18:81–83
  22. Hall JG, Pallister PD, Clarren SK, et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly–a new syndrome? Part I: clinical, causal, and pathogenetic considerations. American Journal of Medical Genetics. 1980;7:47–74
  23. Kang S, Graham JM, Olney AH, et al. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nature Genetics. 1997;15:266–268
  24. Wang B, Fallon JF, Beachy PA. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell. 2000;100:423–434
  25. Shin SH, Kogerman P, Lindstrom E, et al. GLI3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localization. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:2880–2884
  26. Yu RN, Ito M, Saunders TL, et al. Role of Ahch in gonadal development and gametogenesis. Nature Genetics. 1998;20:353–357
  27. Babu PS, Bavers DL, Beuschlein F, et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology. 2002;143:665–673
  28. Park SY, Meeks JJ, Raverot G, et al. Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development. Development. 2005;132:2415–2423
  29. Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature. 1994;372:635–641
  30. Phelan JK, McCabe ER. Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenita. Human Mutation. 2001;18:472–487
  31. Lin L, Gu WX, Ozisik G, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. The Journal of Clinical Endocrinology Metabolism. 2006;91:3048–3054
  32. Achermann JC, Ito M, Hindmarsh PC, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics. 1999;22:125–126
  33. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. American Journal of Human Genetics. 2000;67:1563–1568
  34. Achermann JC, Ozisik G, Ito M, et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. The Journal of Clinical Endocrinology Metabolism. 2002;87:1829–1833
  35. Correa RV, Domenice S, Bingham NC, et al. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. The Journal of Clinical Endocrinology Metabolism. 2004;89:1767–1772
  36. Hasegawa T, Fukami M, Sato N, et al. Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. The Journal of Clinical Endocrinology Metabolism. 2004;89:5930–5935
  37. Mallet D, Bretones P, Michel-Calemard L, et al. Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. The Journal of Clinical Endocrinology Metabolism. 2004;89:4829–4832
  38. Lin L, Philibert P, Ferraz-de-Souza B, et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. The Journal of Clinical Endocrinology Metabolism. 2007;92:991–999
  39. Bamforth SD, Braganca J, Eloranta JJ, et al. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nature Genetics. 2001;29:469–474
  40. Krude H, Biebermann H, Luck W, et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genetics. 1998;19:155–157
  41. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics. 1997;16:303–306
  42. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. The Journal of Clinical Investigation. 2003;112:1550–1560
  43. Mullis PE. Transcription factors in pituitary development. Molecular and Cellular Endocrinology. 2001;185:1–16
  44. Lamolet B, Pulichino AM, Lamonerie T, et al. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell. 2001;104:849–859
  45. Pulichino AM, Vallette-Kasic S, Couture C, et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes & Development. 2003;17:711–716
  46. Metherell LA, Savage MO, Dattani M, et al. TPIT mutations are associated with early-onset, but not late-onset isolated ACTH deficiency. European Journal of Endocrinology. 2004;151:463–465
  47. Vallette-Kasic S, Brue T, Pulichino AM, et al. Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. The Journal of Clinical Endocrinology Metabolism. 2005;90:1323–1331
  48. Clark AJ, Weber A. Adrenocorticotropin insensitivity syndromes. Endocrine Reviews. 1998;19:828–843
  49. Fluck CE, Martens JW, Conte FA, et al. Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay. The Journal of Clinical Endocrinology Metabolism. 2002;87:4318–4323
  50. Clark AJ, Metherell LA, Cheetham ME, et al. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends in Endocrinology and Metabolism. 2005;16:451–457
  51. Lin L, Hindmarsh PC, Metherell LA, et al. Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clinical Endocrinology. 2007;66:205–210
  52. Elias LL, Huebner A, Metherell LA, et al. Tall stature in familial glucocorticoid deficiency. Clinical Endocrinology. 2000;53:423–430
  53. Metherell LA, Chapple JP, Cooray S, et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nature Genetics. 2005;37:166–170
  54. Allgrove J, Clayden GS, Grant DB, et al. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet. 1978;1:1284–1286
  55. Houlden H, Smith S, De Carvalho M, et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain. 2002;125:2681–2690
  56. Tullio-Pelet A, Salomon R, Hadj-Rabia S, et al. Mutant WD-repeat protein in triple-A syndrome. Nature Genetics. 2000;26:332–335
  57. Handschug K, Sperling S, Yoon SJ, et al. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Human Molecular Genetics. 2001;10:283–290
  58. Huebner A, Mann P, Rohde E, et al. Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome. Molecular and Cellular Biology. 2006;26:1879–1887
  59. Rainey WE, Carr BR, Wang ZN, et al. Gene profiling of human fetal and adult adrenals. The Journal of Endocrinology. 2001;171:209–215
  60. Carr BR, Simpson ER. Cholesterol synthesis in human fetal tissues. The Journal of Clinical Endocrinology Metabolism. 1982;55:447–452
  61. Doody KM, Carr BR, Rainey WE, et al. 3β-hydroxysteroid dehydrogenase/isomerase in the fetal zone and neocortex of the human fetal adrenal gland. Endocrinology. 1990;126:2487–2492
  62. Narasaka T, Suzuki T, Moriya T, et al. Temporal and spatial distribution of corticosteroidogenic enzymes immunoreactivity in developing human adrenal. Molecular and Cellular Endocrinology. 2001;174:111–120
  63. Bassett MH, Suzuki T, Sasano H, et al. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Molecular Endocrinology. 2004;18:279–290
  64. Martin LJ, Tremblay JJ. The human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor Nur77 in steroidogenic cells. Endocrinology. 2005;146:861–869
  65. Lu L, Suzuki T, Yoshikawa Y, et al. Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders. The Journal of Clinical Endocrinology Metabolism. 2004;89:4113–4118
  66. LaVoie HA. The role of GATA in mammalian reproduction. Experimental Biology and Medicine (Maywood, N.J.). 2003;228:1282–1290
  67. Pikkarainen S, Tokola H, Kerkela R, et al. GATA transcription factors in the developing and adult heart. Cardiovascular Research. 2004;63:196–207
  68. Kiiveri S, Liu J, Westerholm-Ormio M, et al. Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue. Endocrinology. 2002;143:3136–3143
  69. Fluck CE, Miller WL. GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. Molecular Endocrinology. 2004;18:1144–1157
  70. Huang N, Dardis A, Miller WL. Regulation of cytochrome b5 gene transcription by Sp3, GATA-6, and steroidogenic factor 1 in human adrenal NCI-H295A cells. Molecular Endocrinology. 2005;19:2020–2034
  71. Saner KJ, Suzuki T, Sasano H, et al. Steroid sulfotransferase 2A1 gene transcription is regulated by steroidogenic factor 1 and GATA-6 in the human adrenal. Molecular Endocrinology. 2005;19:184–197
  72. Han VK, Lund PK, Lee DC, et al. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. The Journal of Clinical Endocrinology Metabolism. 1988;66:422–429
  73. Mesiano S, Jaffe RB. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids. 1997;62:62–72
  74. Baxter RC. Biochemical characterization of insulin-like growth factor binding proteins. Acta Endocrinologica. 1991;124(Suppl 2):33–40
  75. Jaffe RB, Mulchahey JJ, Di Blasio AM, et al. Peptide regulation of pituitary and target tissue function and growth in the primate fetus. Recent Progress in Hormone Research. 1988;44:431–549
  76. Ducsay CA, Hess DL, McClellan MC, et al. Endocrine and morphological maturation of the fetal and neonatal adrenal cortex in baboons. The Journal of Clinical Endocrinology Metabolism. 1991;73:385–395
  77. Weber MM, Fottner C, Schmidt P, et al. Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis. Endocrinology. 1999;140:1537–1543
  78. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. The Journal of Clinical Endocrinology Metabolism. 1993;76:968–976
  79. Mesiano S, Katz SL, Lee JY, et al. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. The Journal of Clinical Endocrinology Metabolism. 1997;82:1390–1396
  80. Coulter CL, Goldsmith PC, Mesiano S, et al. Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology. 1996;137:4953–4959
  81. Coulter CL, Goldsmith PC, Mesiano S, et al. Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology. 1996;137:4487–4498
  82. Crickard K, Ill CR, Jaffe RB. Control of proliferation of human fetal adrenal cells in vitro. The Journal of Clinical Endocrinology Metabolism. 1981;53:790–796
  83. Mesiano S, Mellon SH, Gospodarowicz D, et al. Basic fibroblast growth factor expression is regulated by corticotropin in the human fetal adrenal: a model for adrenal growth regulation. Proceeedings of the National Academy of Sciences of the United States of America. 1991;88:5428–5432
  84. Spencer SJ, Rabinovici J, Mesiano S, et al. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. The Journal of Clinical Investigation. 1992;90:142–149
  85. Ishimoto H, Muench MO, Higuchi T, et al. Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland. The Journal of Clinical Endocrinology Metabolism. 2006;91:4050–4056
  86. Young MC, Laurence KM, Hughes IA. Relationship between fetal adrenal morphology and anterior pituitary function. Hormone Research. 1989;32:130–135
  87. Albrecht ED, Aberdeen GW, Babischkin JS, et al. Biphasic developmental expression of adrenocorticotropin receptor messenger ribonucleic acid levels in the baboon fetal adrenal gland. Endocrinology. 1996;137:1292–1298
  88. Leavitt MG, Aberdeen GW, Burch MG, et al. Inhibition of fetal adrenal adrenocorticotropin receptor messenger ribonucleic acid expression by betamethasone administration to the baboon fetus in late gestation. Endocrinology. 1997;138:2705–2712
  89. Seron-Ferre M, Rose JC, Parer JT, et al. In vivo regulation of the fetal rhesus monkey adrenal gland. Endocrinology. 1978;103:368–375
  90. Bocian-Sobkowska J, Malendowicz LK, Wozniak W. Comparative stereological study on zonation and cellular composition of adrenal glands of normal and anencephalic human fetuses. I. Zonation of the gland. Histology and Histopathology. 1997;12:311–317
  91. Leavitt MG, Albrecht ED, Pepe GJ. Development of the baboon fetal adrenal gland: regulation of the ontogenesis of the definitive and transitional zones by adrenocorticotropin. The Journal of Clinical Endocrinology Metabolism. 1999;84:3831–3835
  92. Aberdeen GW, Babischkin JS, Davies WA, et al. Decline in adrenocorticotropin receptor messenger ribonucleic acid expression in the baboon fetal adrenocortical zone in the second half of pregnancy. Endocrinology. 1997;138:1634–1641
  93. Seron-Ferre M, Lawrence CC, Jaffe RB. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. The Journal of Clinical Endocrinology Metabolism. 1978;46:834–837
  94. Smith R, Mesiano S, Chan EC, et al. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. The Journal of Clinical Endocrinology Metabolism. 1998;83:2916–2920
  95. Albrecht ED, Aberdeen GW, Pepe GJ. Estrogen elicits cortical zone-specific effects on development of the primate fetal adrenal gland. Endocrinology. 2005;146:1737–1744
  96. Shifren JL, Mesiano S, Taylor RN, et al. Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. The Journal of Clinical Endocrinology Metabolism. 1998;83:1342–1347
  97. Ishimoto H, Ginzinger DG, Jaffe RB. Adrenocorticotropin preferentially up-regulates angiopoietin 2 in the human fetal adrenal gland: implications for coordinated adrenal organ growth and angiogenesis. The Journal of Clinical Endocrinology Metabolism. 2006;91:1909–1915
  98. Chamoux E, Otis M, Gallo-Payet N. A connection between extracellular matrix and hormonal signals during the development of the human fetal adrenal gland. Brazilian Journal of Medical and Biological Research. 2005;38:1495–1503
  99. Slater EP, Diehl SM, Langer P, et al. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. European Journal of Endocrinology. 2006;154:587–598
  100. Giordano TJ, Thomas DG, Kuick R, et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. The American Journal of Pathology. 2003;162:521–531
  101. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:9330–9335
  102. West AN, Neale GA, Pounds S, et al. Gene expression profiling of childhood adrenocortical tumors. Cancer Research. 2007;67:600–608
  103. Kiiveri S, Liu J, Heikkila P, et al. Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors. Endocrine Research. 2004;30:919–923
  104. Rosenberg D, Groussin L, Jullian E, et al. Transcription factor 3′,5′-cyclic adenosine 5′-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development. The Journal of Clinical Endocrinology Metabolism. 2003;88:3958–3965

PII: S1521-690X(07)00061-9

doi: 10.1016/j.beem.2007.07.008

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 77-93 , February 2008

Article Tools

* Image Usage & Resolution